• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第二代药物洗脱支架中早期与晚期支架内再狭窄的特点:光学相干断层成像研究。

Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.

机构信息

Cardiovascular Research Foundation, New York, NY, USA.

出版信息

EuroIntervention. 2017 Jun 20;13(3):294-302. doi: 10.4244/EIJ-D-16-00787.

DOI:10.4244/EIJ-D-16-00787
PMID:28320686
Abstract

AIMS

In-stent restenosis (ISR) is an important cause of drug-eluting stent (DES) failure and target vessel revascularisation. In this study we aimed to evaluate differences between early and late-presenting restenosis in second-generation DES using optical coherence tomography (OCT).

METHODS AND RESULTS

Overall, 171 cases of second-generation DES ISR with a follow-up OCT minimum lumen area <3.0 mm2 were included: 33.3% of patients (n=57) had early ISR, and 66.7% (n=114) had late ISR (duration from stent implantation >1 year). Minimum stent area (MSA) <4.0 mm2, neointimal thickness <100 µm, and heterogeneous neointimal hyperplasia (NIH) were more prevalent in early ISR, whereas NIH with neoatherosclerosis trended towards being more frequent for late ISR (28.9% vs. 15.8%, p=0.06). Multivariable analysis revealed that duration from implantation >2 years, absence of statin use, and NIH >50% were independent predictors for neoatherosclerosis (all p<0.05).

CONCLUSIONS

OCT morphological characteristics of second-generation DES ISR differ between early and late presentation. Early ISR was associated with MSA <4.0 mm2, while neoatherosclerosis contributed more commonly to late ISR.

摘要

目的

支架内再狭窄(ISR)是药物洗脱支架(DES)失败和靶血管血运重建的重要原因。本研究旨在通过光学相干断层扫描(OCT)评估第二代 DES 中早期和晚期再狭窄的差异。

方法和结果

共纳入 171 例第二代 DES-ISR 患者,随访 OCT 最小管腔面积<3.0mm2:33.3%(n=57)的患者为早期 ISR,66.7%(n=114)为晚期 ISR(支架植入后>1 年)。早期 ISR 中最小支架面积(MSA)<4.0mm2、新生内膜厚度<100µm 和不均匀性新生内膜增生(NIH)更为常见,而晚期 ISR 中伴有新生动脉粥样硬化的 NIH 更为常见(28.9%比 15.8%,p=0.06)。多变量分析显示,植入后>2 年、无他汀类药物使用和 NIH>50%是新生动脉粥样硬化的独立预测因素(均 p<0.05)。

结论

第二代 DES-ISR 的 OCT 形态学特征在早期和晚期表现不同。早期 ISR 与 MSA<4.0mm2 相关,而晚期 ISR 中更常见的是新生动脉粥样硬化。

相似文献

1
Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.第二代药物洗脱支架中早期与晚期支架内再狭窄的特点:光学相干断层成像研究。
EuroIntervention. 2017 Jun 20;13(3):294-302. doi: 10.4244/EIJ-D-16-00787.
2
In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.使用频域光学相干断层扫描评估的支架内再狭窄显示第二代药物洗脱支架中冠状动脉愈合过程顺利。
Singapore Med J. 2019 Jan;60(1):48-51. doi: 10.11622/smedj.2018038. Epub 2018 Apr 10.
3
Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.第二代药物洗脱支架内早期与晚期支架内再狭窄的支架内新生动脉粥样硬化及组织特征比较:一项光学相干断层扫描研究
Int J Cardiovasc Imaging. 2017 Oct;33(10):1463-1472. doi: 10.1007/s10554-017-1146-7. Epub 2017 Apr 25.
4
[Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].[药物洗脱支架植入术后早期及极晚期支架再狭窄的光学相干断层扫描分析]
Zhonghua Yi Xue Za Zhi. 2017 Jun 20;97(23):1778-1783. doi: 10.3760/cma.j.issn.0376-2491.2017.23.005.
5
Difference of Tissue Characteristics Between Early and Late Restenosis After Second-Generation Drug-Eluting Stents Implantation - An Optical Coherence Tomography Study.第二代药物洗脱支架植入术后早期和晚期再狭窄组织特征的差异——光学相干断层扫描研究
Circ J. 2017 Mar 24;81(4):450-457. doi: 10.1253/circj.CJ-16-1069. Epub 2017 Jan 27.
6
Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.在再狭窄裸金属支架以及第一代和第二代药物洗脱支架中,通过光学相干断层扫描评估的新型动脉粥样硬化。
Int J Cardiovasc Imaging. 2017 Aug;33(8):1115-1124. doi: 10.1007/s10554-017-1106-2. Epub 2017 Mar 9.
7
Optical coherence tomographic analysis of drug-eluting in-stent restenosis at different times: A STROBE compliant study.不同时间药物洗脱支架内再狭窄的光学相干断层扫描分析:一项遵循STROBE规范的研究
Medicine (Baltimore). 2018 Aug;97(34):e12117. doi: 10.1097/MD.0000000000012117.
8
Differences in optical coherence tomographic findings and clinical outcomes between excimer laser and cutting balloon angioplasty for focal in-stent restenosis lesions.准分子激光与切割球囊血管成形术治疗局灶性支架内再狭窄病变的光学相干断层扫描结果及临床结局差异。
J Invasive Cardiol. 2012 Oct;24(10):478-83.
9
Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.光学相干断层扫描评估的组织特征与经皮冠状动脉介入治疗支架内再狭窄病变的中期结果之间的关联:球囊血管成形术、紫杉醇涂层球囊扩张术和药物洗脱支架植入术的比较
Eur Heart J Cardiovasc Imaging. 2015 Oct;16(10):1101-11. doi: 10.1093/ehjci/jev031. Epub 2015 Mar 9.
10
Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study.第一代药物洗脱支架植入后早期、晚期和极晚期再狭窄病变组织特征的形态学差异:光学相干断层扫描研究。
Eur Heart J Cardiovasc Imaging. 2013 Mar;14(3):276-84. doi: 10.1093/ehjci/jes183. Epub 2012 Sep 3.

引用本文的文献

1
Elevated Lipoprotein(a) Predicts Stent Edge Restenosis and Adverse Two-Year Outcomes After PCI: An Intravascular Ultrasound Study.脂蛋白(a)升高预测经皮冠状动脉介入治疗后支架边缘再狭窄及两年不良预后:一项血管内超声研究
Int J Gen Med. 2025 Jul 5;18:3713-3725. doi: 10.2147/IJGM.S533584. eCollection 2025.
2
Intravascular ultrasound assessment of stent edge restenosis mechanisms and treatment outcomes following percutaneous coronary intervention.经皮冠状动脉介入治疗后支架边缘再狭窄机制及治疗结果的血管内超声评估
Sci Rep. 2025 May 10;15(1):16298. doi: 10.1038/s41598-025-01381-9.
3
Stent Underexpansion Is an Underestimated Cause of Intrastent Restenosis: Insights From RESTO Registry.
支架扩张不足是支架内再狭窄的一个被低估的原因:RESTO 注册研究的新认识。
J Am Heart Assoc. 2024 Nov 5;13(21):e036065. doi: 10.1161/JAHA.124.036065. Epub 2024 Oct 25.
4
SCAI Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosis.SCAI关于支架内再狭窄和支架血栓形成管理的专家共识声明。
J Soc Cardiovasc Angiogr Interv. 2023 May 18;2(4):100971. doi: 10.1016/j.jscai.2023.100971. eCollection 2023 Jul-Aug.
5
Neoatherosclerosis: A Distinctive Pathological Mechanism of Stent Failure.新型动脉粥样硬化:支架失败的独特病理机制
Rev Cardiovasc Med. 2024 Mar 7;25(3):95. doi: 10.31083/j.rcm2503095. eCollection 2024 Mar.
6
The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study.性别差异对药物洗脱支架内支架再狭窄新生内膜特征的影响:一项光学相干断层扫描研究。
Heliyon. 2023 Aug 11;9(8):e19073. doi: 10.1016/j.heliyon.2023.e19073. eCollection 2023 Aug.
7
Drug-coated balloon therapy is more effective in treating late drug-eluting stent in-stent restenosis than the early occurring one-a systematic review and meta-analysis.药物涂层球囊治疗晚期药物洗脱支架内再狭窄比早期发生的更有效——一项系统评价和荟萃分析。
Front Cardiovasc Med. 2023 Jun 5;10:1062130. doi: 10.3389/fcvm.2023.1062130. eCollection 2023.
8
Mechanisms and treatment outcomes of ostial right coronary artery in-stent restenosis.开口右冠状动脉支架内再狭窄的机制和治疗结果。
EuroIntervention. 2023 Aug 7;19(5):e383-e393. doi: 10.4244/EIJ-D-23-00107.
9
Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence.当代药物洗脱支架的支架内血栓形成与再狭窄:预测因素及当前证据
J Clin Med. 2023 Feb 3;12(3):1238. doi: 10.3390/jcm12031238.
10
Optical Coherence Tomography of the Coronary Arteries.冠状动脉光学相干断层扫描
Int J Angiol. 2021 Mar;30(1):29-39. doi: 10.1055/s-0041-1724019. Epub 2021 Feb 12.